CHICAGO--(BUSINESS WIRE)--SAMDI Tech Inc., the industry’s leading provider of label-free drug discovery solutions, is pleased to announce that Dr. Milan Mrksich, founder of SAMDI Tech and professor at Northwestern University, has been selected to serve as a scientific advisor for SLAS Technology. A rigorously peer-reviewed, multidisciplinary journal of the Society for Laboratory Automation and Screening (SLAS), SLAS Technology is devoted to the advancement of technology for life sciences and biomedical research and development.
Dr. Mrksich, inventor of the SAMDI technology, joins other elite members of the scientific community in his service on the advisory board. Over the course of his five-year term, Dr. Mrksich will advise the journal on technology trends in the field.
“Milan’s accomplishments are highly regarded in the scientific community,” said SAMDI Tech CEO Emilio Córdova, Ph.D., MBA. “His appointment to serve on this advisory committee reflects his innovation, commitment and leadership. We are proud he is a part of our team.”
SAMDI (Self-Assembled Monolayer Desorption Ionization) technology was first described by Dr. Mrksich in 2002 as a solution to the challenges and pitfalls of label-dependent biochemical assays. Dr. Mrksich found that self-assembled monolayers (SAMs) could be analyzed by Matrix Assisted Laser Desorption/Ionization (MALDI) mass spectrometry, a key discovery that provided the foundation for the label-free and high-throughput SAMDI assay.
About SAMDI Tech
SAMDI Tech Inc. delivers better, faster,
label-free assay development, high-throughput screening and peptide
substrate discovery solutions for early-stage drug candidate selection.
Our highly skilled team believes in results and uses proprietary
industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption
Ionization) technology to deliver decision-making data fast. Learn more
about SAMDI Tech at www.samditech.com.
